BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marot A, Barbosa J, Duran R, Deltenre P, Denys A. Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion. Diagnostic and Interventional Imaging 2019;100:147-56. [DOI: 10.1016/j.diii.2018.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim CY, Pinchot JW, Ahmed O, Braun AR, Cash BD, Feig BW, Kalva SP, Knavel Koepsel EM, Scheidt MJ, Schramm K, Sella DM, Weiss CR, Hohenwalter EJ. ACR Appropriateness Criteria® Radiologic Management of Gastric Varices. Journal of the American College of Radiology 2020;17:S239-54. [DOI: 10.1016/j.jacr.2020.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Clin Res Hepatol Gastroenterol 2020;44:491-6. [PMID: 32819872 DOI: 10.1016/j.clinre.2020.03.016] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li H, Sun PM, Sun HW, Cui Y. Progress in clinical diagnosis and treatment of cavernous transformation of the portal vein. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 662-669 [DOI: 10.11569/wcjd.v29.i12.662] [Reference Citation Analysis]
5 Wei B, Huang Z, Tang C. Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein. Front Med 2022;9:853138. [DOI: 10.3389/fmed.2022.853138] [Reference Citation Analysis]
6 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
7 Cannella R, Tselikas L, Douane F, Cauchy F, Rautou P, Duran R, Ronot M. Imaging-guided interventions modulating portal venous flow: evidence and controversies. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100484] [Reference Citation Analysis]
8 Kobe A, Puippe G, Müllhaupt B, Pfammatter T. Recanalization of Chronic Noncirrhotic, Nonmalignant Splanchnic Thromboses is Feasible: A Transsplenic Assisted Patient-Tailored Approach. J Vasc Interv Radiol 2021;32:1377-85. [PMID: 34462082 DOI: 10.1016/j.jvir.2021.05.012] [Reference Citation Analysis]
9 Thompson SM, Fleming CJ, Yohanathan L, Truty MJ, Kendrick ML, Andrews JC. Portomesenteric Venous Complications after Pancreatic Surgery with Venous Reconstruction: Imaging and Intervention. Radiographics 2020;40:531-44. [PMID: 31977263 DOI: 10.1148/rg.2020190100] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Valla DC. Recent developments in the field of vascular liver diseases. Liver Int 2020;40 Suppl 1:142-8. [PMID: 32077611 DOI: 10.1111/liv.14348] [Reference Citation Analysis]
11 Vermersch M, Denys A, Artru F, Tsoumakidou G, Villard N, Duran R, Hocquelet A. Transhepatic tract hemostasis using thermal-ablation after percutaneous portal vein access. BJR|case reports 2022;8:20210080. [DOI: 10.1259/bjrcr.20210080] [Reference Citation Analysis]